| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.05 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.06 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |